Form 4 for MRNA Moderna
Accepted 2021-08-24 00:00:00 ET · period of report 2021-08-20 · accession 0001127602-21-024234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-24 | 2021-08-20+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $382.50 | -10.0K | 0 | -100% | -$3.82M |
| DM | 2021-08-24 | 2021-08-20+ | MRNA | Andres Juan | See remarks | M - OptEx | $12.21 | +10.0K | 5,000 | New | +$122.1K |
| DM | 2021-08-24 | 2021-08-20+ | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -10.0K | 334.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | S | D | 5,000 | $390.11 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-23 | M | A | 5,000 | $12.21 | 5,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-20 | S | D | 5,000 | $374.88 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-20 | M | A | 5,000 | $12.21 | 5,000 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-23 | M | D | 5,000 | $0.00 | 329,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-20 | M | D | 5,000 | $0.00 | 334,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. |